BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 28600110)

  • 1. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
    Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.
    Hanaki H; Yamamoto H; Sakane H; Matsumoto S; Ohdan H; Sato A; Kikuchi A
    Mol Cancer Ther; 2012 Feb; 11(2):298-307. PubMed ID: 22101459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
    Wu C; Qiu S; Lu L; Zou J; Li WF; Wang O; Zhao H; Wang H; Tang J; Chen L; Xu T; Sun Z; Liao W; Luo G; Lu X
    Nat Commun; 2014; 5():3149. PubMed ID: 24476626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
    Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
    EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
    Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
    Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds.
    Madan B; Walker MP; Young R; Quick L; Orgel KA; Ryan M; Gupta P; Henrich IC; Ferrer M; Marine S; Roberts BS; Arthur WT; Berndt JD; Oliveira AM; Moon RT; Virshup DM; Chou MM; Major MB
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E2945-54. PubMed ID: 27162353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frizzled7 as an emerging target for cancer therapy.
    King TD; Zhang W; Suto MJ; Li Y
    Cell Signal; 2012 Apr; 24(4):846-51. PubMed ID: 22182510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
    Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
    Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers.
    Conboy CB; Vélez-Reyes GL; Rathe SK; Abrahante JE; Temiz NA; Burns MB; Harris RS; Starr TK; Largaespada DA
    DNA Cell Biol; 2021 Jan; 40(1):70-79. PubMed ID: 33320737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
    Anastas JN; Kulikauskas RM; Tamir T; Rizos H; Long GV; von Euw EM; Yang PT; Chen HW; Haydu L; Toroni RA; Lucero OM; Chien AJ; Moon RT
    J Clin Invest; 2014 Jul; 124(7):2877-90. PubMed ID: 24865425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSPO2 enhances cell invasion and migration via the WNT/β-catenin pathway in human gastric cancer.
    Zhang H; Han X; Wei B; Fang J; Hou X; Lan T; Wei H
    J Cell Biochem; 2019 Apr; 120(4):5813-5824. PubMed ID: 30362605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2.
    Masckauchán TN; Agalliu D; Vorontchikhina M; Ahn A; Parmalee NL; Li CM; Khoo A; Tycko B; Brown AM; Kitajewski J
    Mol Biol Cell; 2006 Dec; 17(12):5163-72. PubMed ID: 17035633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells.
    Zhang Z; Gao S; Xu Y; Zhao C
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
    Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.